Dr. Nirmal Raut Specialist in Medical Oncology

Area of Expertise

Management of solid tumors and hematological malignancies with evidence-based chemotherapy, targeted therapy, and immunotherapy
Specialized focus on breast cancer, lung cancer, non-Hodgkin lymphoma, and multiple myeloma
Molecular oncology and translational cancer research

Research & Publications

Dr. Raut has been actively involved in Phase III clinical trials for breast cancer, lung cancer, lymphoma, and multiple myeloma. His research has contributed to the advancement of novel therapies including Rituximab, paclitaxel, temozolomide, and lung cancer vaccines.

Endoxifen in ER+/PR+/Her2-negative metastatic breast cancer.

Ribociclib with letrozole as adjuvant hormonal therapy in high-risk breast cancer.
Selinexor with bortezomib and dexamethasone in relapsed multiple myeloma
Neoadjuvant Chemotherapy in Breast Cancer – What Have We Learned So Far – Indian Journal of Medical and Paediatric Oncology (2010).
First Line Gefitinib in Advanced Carcinoma of Lung – A Prospective Study of 490 Patients in India (2010).
Concurrent and Adjuvant Temozolomide with Radiotherapy in Paediatric Brainstem Glioma – International Journal of Radiation Oncology, Biology and Physics (2010).
Contributions to Lymphoma Newsletter and Pancreatic Cancer India forum.
Abstract presentations at international platforms including ASCO (USA), World Lung Cancer Conference (San Francisco), and Asia Pacific Lung Cancer Conference (Hyderabad).

Awards & Accolades

Certification by the European Society of Medical Oncologists (ESMO) – 2016
Recognized speaker and contributor at leading global oncology forums including ASCO and World Lung Cancer Conference
Regular faculty at national oncology meetings and member of multiple professional oncology societies.

Other Doctors